Refractory Langerhans cell histiocytosis

Drug	Drug Name	Drug Description
DB00631	Clofarabine	A purine nucleoside used to treat relapsed or refractory acute lymphoblastic leukemia in patients 1 to 21 years old.

Drug	Drug Name	Target	Type
DB00631	Clofarabine	DNA polymerase alpha catalytic subunit	target
DB00631	Clofarabine	Ribonucleoside-diphosphate reductase large subunit	target
DB00631	Clofarabine	Deoxycytidine kinase	enzyme
DB00631	Clofarabine	DNA	target
DB00631	Clofarabine	ATP-binding cassette sub-family G member 2	transporter

Drug	Drug Name	Phase	Status	Count
DB14860	Ensartinib	2	Recruiting	2
DB12147	Erdafitinib	2	Recruiting	1
DB12147	Erdafitinib	2	Suspended	1
DB15127	Hydrogen	2	Recruiting	1
DB14568	Ivosidenib	2	Recruiting	1
DB12167	LY-3023414	2	Recruiting	2
DB14723	Larotrectinib	2	Recruiting	2
DB14123	Menthol	2	Recruiting	1
DB09074	Olaparib	2	Active Not Recruiting	1
DB09074	Olaparib	2	Recruiting	1
DB09073	Palbociclib	2	Active Not Recruiting	1
DB09073	Palbociclib	2	Recruiting	1
DB15685	Selpercatinib	2	Recruiting	2
DB11689	Selumetinib	2	Recruiting	1
DB14546	Sulfate ion	2	Recruiting	2
DB12887	Tazemetostat	2	Active Not Recruiting	1
DB12887	Tazemetostat	2	Recruiting	1
DB04960	Tipifarnib	2	Recruiting	2
DB15266	Tovorafenib	2	Not Yet Recruiting	1
DB13930	Ulixertinib	2	Active Not Recruiting	1
DB13930	Ulixertinib	2	Recruiting	1
DB08881	Vemurafenib	2	Recruiting	1
DB13104	X-396	2	Recruiting	2